COMP <GO>
MELI vs ACN // RSI-14 & 200D SMA MOMENTUM
MercadoLibre Inc. (NASDAQ) VS. Accenture plc (Ireland) (Class A) (NYSE) • 15-METRIC TALLY: MELI 4
— ACN 8
▲ RSI-14 & 200D SMA MOMENTUM LEADER: ACN
LAST: $1,624.53 (-2.14%) • MKT CAP: $84.16B
rsi-technicals
35.7
LAST: $258.24 (+4.46%) • MKT CAP: $165.32B
rsi-technicals
62.1
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MELI VS. ACN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MELI | ACN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 63.20% | 31.90% | +31.30 | MELI | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 13.90% | 23.60% | -9.70 | ACN | /roic <GO> |
| EV/EBITDA & P/E Valuation | 24.0x | 15.7x | +8.30 | ACN | /valuation <GO> |
| Free Cash Flow Yield | 13.31% | 6.58% | +6.73 | MELI | /fcf-yield <GO> |
| Operating Margin | 15.70% | 14.70% | +1.00 | MELI | /operating-margins <GO> |
| Net Profit Margin | 9.80% | 11.00% | -1.20 | ACN | /net-margins <GO> |
| Revenue Growth (YoY) | 34.30% | 7.40% | +26.90 | MELI | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.46 | 5.42 | -2.96 | ACN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 8/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 35.7 | 62.1 | -26.40 | ACN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.93 | 0.96 | -0.03 | ACN | /macro-sensitivity <GO> |
| Forward P/E Multiple | 35.4x | 20.0x | +15.40 | ACN | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $84.16B | $165.32B | -$81.16B | ACN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MELI REV | ACN REV | MELI GROSS % | ACN GROSS % | MELI FCF | ACN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $20.34B | $69.67B | 63.2% | 31.9% | $11.20B | $10.87B |
| FY 2024 | $15.14B | $64.90B | 63.3% | 32.6% | $7.24B | $8.61B |
| FY 2023 | $10.49B | $64.11B | — | — | $4.67B | $6.64B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MELI // BETA 0.93
ACN // BETA 0.96